Avantor (AVTR) Set to Announce Earnings on Friday

Avantor (NYSE:AVTR) is set to post its quarterly earnings results before the market opens on Friday, April 26th. Analysts expect Avantor to post earnings of $0.20 per share for the quarter. Avantor has set its FY 2024 guidance at 0.960-1.040 EPS.Investors interested in participating in the company’s conference call can do so using this link.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, February 14th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.22 by $0.03. The company had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The firm’s revenue was down 4.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.32 EPS. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Avantor Trading Up 5.1 %

AVTR stock opened at $25.66 on Wednesday. The company has a market capitalization of $17.40 billion, a PE ratio of 53.45, a P/E/G ratio of 2.45 and a beta of 1.37. Avantor has a 12 month low of $16.63 and a 12 month high of $26.16. The firm’s 50-day moving average is $25.03 and its 200 day moving average is $22.55. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.05.

Insider Buying and Selling

In related news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the completion of the sale, the executive vice president now owns 101,143 shares of the company’s stock, valued at approximately $2,476,992.07. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

AVTR has been the topic of a number of recent analyst reports. Royal Bank of Canada raised their price target on shares of Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. UBS Group raised their price target on shares of Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a report on Thursday, February 15th. JPMorgan Chase & Co. raised their price target on shares of Avantor from $26.00 to $29.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. Raymond James lifted their target price on shares of Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a research note on Friday, January 26th. Finally, Citigroup lifted their target price on shares of Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a research note on Thursday, February 15th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $26.71.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.